Silver Book Fact

In one study, deep-brain stimulation for Parkinson’s patients significantly reduced their required dosages of antiparkinsonian medications, consequently decreasing their medication costs by 32% 1 year after surgery, and 39% 2 years after.

Charles P, Padaliya B, Newman W, Gill C, et al. Deep Brain Stimulation of the Subthalamic Nucleus Reduces Antiparkinsonian Medication Costs. Parkinsonism & Related Disorders. 2004; 10(8): 475-9. https://www.prd-journal.com/article/S1353-8020(04)00096-3/fulltext

Reference

Title
Deep Brain Stimulation of the Subthalamic Nucleus Reduces Antiparkinsonian Medication Costs
Publication
Parkinsonism & Related Disorders
Publication Date
2004
Authors
Charles P, Padaliya B, Newman W, Gill C, et al.
Volume & Issue
Volume 10, Issue 8
Pages
475-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Medicare Costs, Slowed Progression  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.  
  • In one study, despite a 4-fold increase in prescription drug spending, overall health spending for Alzheimer’s patients undergoing drug therapy went down by 1/3.  
  • New Medicines in Development for Parkinson’s Disease in 2018